These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18083018)

  • 1. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.
    McMahon M; Hahn BH
    Curr Opin Immunol; 2007 Dec; 19(6):633-9. PubMed ID: 18083018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
    Bassi N; Ghirardello A; Iaccarino L; Zampieri S; Rampudda ME; Atzeni F; Sarzi-Puttini P; Shoenfeld Y; Doria A
    Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis in autoimmune diseases.
    Matsuura E; Kobayashi K; Lopez LR
    Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
    George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y
    Lupus; 1999; 8(3):220-6. PubMed ID: 10342715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein functionality in systemic lupus erythematosus.
    Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
    Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
    Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Beggio S; Matsuura E; Doria A
    Autoimmunity; 2009 May; 42(4):289-91. PubMed ID: 19811279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
    Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
    J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
    Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
    Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLE, atherosclerosis and cardiovascular disease.
    Frostegård J
    J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.
    Hahn BH; McMahon M
    Lupus; 2008 May; 17(5):368-70. PubMed ID: 18490409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity, oxidized LDL and cardiovascular disease.
    Frostegård J
    Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis in systemic lupus erythematosus.
    Sherer Y; Zinger H; Shoenfeld Y
    Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL.
    Yassin LM; Londoño J; Montoya G; De Sanctis JB; Rojas M; Ramírez LA; García LF; Vásquez G
    Autoimmunity; 2011 May; 44(3):201-10. PubMed ID: 21231894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
    Kobayashi K; Lopez LR; Matsuura E
    Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.
    Reiss AB; Anwar K; Merrill JT; Chan ES; Awadallah NW; Cronstein BN; Michael Belmont H; Belilos E; Rosenblum G; Belostocki K; Bonetti L; Hasneen K; Carsons SE
    Rheumatol Int; 2010 Mar; 30(5):591-8. PubMed ID: 19547978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases.
    Wang Y; Yu H; He J
    Discov Med; 2020; 30(159):49-56. PubMed ID: 33357362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.